Research Study
Coin Report: Ethereum (ETH)
An overview of Ethereum and its potential use cases
August 21, 2025 • 35 min read
Executive Summary
Ethereum launched in 2013 with the support of Vitalik Buterin and seven other co-founders in an effort to build upon Bitcoin’s success as the first decentralized peer-to-peer electronic cash system. While its co-founders recognized the significance of Bitcoin’s breakthrough, they wanted to further expand its technology to make a programmable blockchain with enhanced functionality. Over ten years later, Ethereum is now both a leading smart contract platform and the second largest digital asset by market cap.
Fidelity Digital Assets’ “Coin Report” series provides readers with a foundational understanding of a unique asset and examines its strengths and weaknesses. Each installment is updated on an ongoing basis as warranted by significant changes in data and developments across the digital assets market.
This report specifically highlights Ethereum and explores its long-term potential in the digital asset market, covering topics including:
- Ethereum’s investment thesis as a technology platform that uses its native token ether as a means of payment
- How Ethereum accrued strong network effects from its first mover advantage as a smart contract platform
- An overview of Ethereum’s fundamental differences compared to Bitcoin and other assets
As the first network to offer developers a digital blank canvas where applications can be coded into existence and secured by a global network of computers, Ethereum helped to revolutionize decentralized applications and enabled their use across the finance industry including payments, trading, lending, and borrowing. However, there is always the possibility that a competitor may overtake Ethereum as the smart contract platform of choice.
Download the report now to uncover in-depth insights about Ethereum’s potential, market trends, and strategic opportunities.
The information herein was prepared by Fidelity Digital Asset Services, LLC (“FDAS LLC”), Fidelity Digital Assets, Ltd (“FDA LTD”), and Fidelity Digital Assets Ireland Limited ("FDA Ireland"). It is for informational purposes only and is not intended to constitute a recommendation, investment advice of any kind, or an offer to buy or sell any asset. Perform your own research and consult a qualified advisor to see if digital assets are an appropriate investment option.
Digital assets are speculative and highly volatile, can become illiquid at any time, and are for investors with a high-risk tolerance. Investors in digital assets could lose the entire value of their investment.
Custody and trading of digital assets are provided by Fidelity Digital Asset Services, LLC, which is chartered as a limited purpose trust company by the New York State Department of Financial Services to engage in virtual currency business (NMLS ID 1773897) ("FDAS LLC"). FDA LTD and FDA Ireland rely on FDAS LLC for these services. FDA LTD is registered with the Financial Conduct Authority under the U.K.’s Money Laundering Regulations. The Financial Ombudsman Service and the Financial Services Compensation Scheme do not apply to the cryptoasset activities carried on by FDA LTD. FDA Ireland is incorporated in Ireland as a private limited company and provides certain virtual asset services described in the Criminal Justice (Money Laundering and Terrorist Financing) Acts 2010 to 2021. FDA Ireland is registered with the Central Bank of Ireland for anti-money laundering and countering the financing of terrorism (AML/CFT) purposes only (C526991).
To the extent this communication constitutes a financial promotion in the U.K., it is issued only to, or directed only at, persons who are: (i) investment professionals within the meaning of Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "FPO"); (ii) high net worth companies and certain other entities falling within Article 49 of the FPO; and (iii) any other persons to whom it may lawfully be communicated.
This information is not intended for distribution to, or use by, anyone in any jurisdiction where such distribution would be contrary to local law or regulation. Persons accessing this information are required to inform themselves about and observe such restrictions.
Views expressed are as of the date indicated, based on the information available at that time, and may change based on market or other conditions. Unless otherwise noted, the opinions provided are those of the speaker or author and not necessarily those of Fidelity Digital Assets or its affiliates. Fidelity Digital Assets does not assume any duty to update any of the information.
FDAS LLC, FDA LTD, and FDA Ireland do not provide tax, legal, investment, or accounting advice. This material is not intended to provide, and should not be relied on, for tax, legal, or accounting advice. Tax laws and regulations are complex and subject to change. You should consult your own tax, legal, and accounting advisors before engaging in any transaction.
Fidelity Digital Assets and the Fidelity Digital Assets logo are registered service marks of FMR LLC.
© 2025 FMR LLC. All rights reserved.